¨º¡Á¨°3|¨¬¨ª?¨®¦Ì?¨º?2??D|?¨®¨¨??¨°¦Ì?1¡è??¡ã¨¹
Íâó|¡Á¡é2¨¢|¦Ì???|?¡§??




¡¡
ÃÀ¹úHTS ±àÂë(ÃÀ¹úº£¹Ø¹ØË°±àÂë)  
ÇëÊäÈëHTS±àÂëµÄǰ°ë²¿·Ö»òÉÌÆ·ÃèÊöµÄ²¿·ÖÄÚÈÝ(Ó¢ÎÄ)   HTS ÆäËû²éѯ¹¤¾ß
    
¡¡
  7/22         
ÃÀ¹úº£¹Ø¹ØË°±àÂë
HTS ±àÂëºó ׺ ÉÌÆ·ÃèÊö ÊýÁ¿µ¥Î» Íê˰˰ÂÊ
1 2
ͨ³£ ÌØ±ð
2922.49.4020Glycine (Aminoacetic acid)kg
2922.49.60003-Aminocrotonic acid, methyl ester; and ¡é/- α-Amino-1,4-cyclohexadiene-1- acetic acidkgFree25%
2922.50Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function:
2922.50.07003,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-¡é/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ¡é/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine)kgFree15.4¡é/kg + 50%
2922.50.1000dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate)kg5.8%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG)15.4¡é/kg + 39%
2922.50.1100Salts of d(-)-p-Hydroxyphenylglycine (¡é/- α-Amino-4-hydroxybenzeneacetic acid)kg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG)15.4¡é/kg + 50%
2923Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined:
2923.20Lecithins and other phosphoaminolipids:
2923.20.1000Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsionkgFree16.5¡é/kg + 30%
2924.29.0100p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamidekgFree15.4¡é/kg + 39.5%
2924.29.1000Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)anilinekg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2¡é/kg + 3.3% (SG)15.4¡é/kg + 58%
2924.29.20002-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinonekg6.5%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG)15.4¡é/kg + 53%
2924.29.23004-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamidekgFree15.4¡é/kg + 58%
2924.29.26003-AminomethoxybenzanilidekgFree15.4¡é/kg + 54.5%
2924.29.2800N-[[(4-Chlorophenyl)amino]carbonyl]-2,6- difluorobenzamide; and 3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)- benzamide (Pronamide)kgFree15.4¡é/kg + 64.5%
2924.29.31004-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-¡é/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamidekg5.8%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG)15.4¡é/kg + 39.5%
2924.29.43003-Ethoxycarbonylaminophenyl-¡é/phenylcarbamate (Desmedipham); and Isopropyl-N-(3-chlorophenyl)car- bamate (CIPC)kg6.5%Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG)15.4¡é/kg + 40.5%
2924.29.5700Diethylaminoacetoxylidide (Lidocaine)kgFree15.4¡é/kg + 101.5%
2924.29.6210Acetaminophenkg
2924.29.7630p-Aminobenzamidekg
2925Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds:
2925.21.0000Imines and their derivatives; salts thereof:
2925.29.1800N,N'-Diphenylguanidine; 3-Dimethylaminomethyleneiminophenol hydrochloride; 1,3-Di-o-tolylguanidine; and N,N-Dimethyl-N'-[3-[[(methylamino)carbonyl]- oxy]phenyl]methanimidamide monohydro- chloridekgFree15.4¡é/kg + 61%
2926.30Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane):
2926.30.20004-Cyano-2-dimethylamino-4,4-diphenylbutanekg6.5%Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.9% (SG)15.4¡é/kg + 65.5%

 7/22          

¨¨¨¨??¨®|¨®?:    ÃÀ¹úº£¹Ø±àÂë²éÕÒ     ²éѯÄÚÈÝ:  

¡Á??¨¹¨®??¡ì2¨¦?¡¥:

I want to Post a new feedback